163 related articles for article (PubMed ID: 23859640)
21. Evaluation of an enzyme immunoassay using neoglycolipids constructed from Candida albicans oligomannosides to define the specificity of anti-mannan antibodies.
Faille C; Mackenzie DW; Michalski JC; Poulain D
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):438-46. PubMed ID: 1425714
[TBL] [Abstract][Full Text] [Related]
22. [Specific soluble cell-wall antigens of "Candida tropicalis" demonstrated by crossed immunoelectrophoresis (author's transl)].
Guinet R; Gabriel S; Oriez F; Bonaly R
Ann Microbiol (Paris); 1979; 130B(4):433-42. PubMed ID: 94248
[TBL] [Abstract][Full Text] [Related]
23. Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody.
Bundle DR; Nycholat C; Costello C; Rennie R; Lipinski T
ACS Chem Biol; 2012 Oct; 7(10):1754-63. PubMed ID: 22877569
[TBL] [Abstract][Full Text] [Related]
24. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
[TBL] [Abstract][Full Text] [Related]
25. The evaluation of β-(1 → 3)-nonaglucoside as an anti-Candida albicans immune response inducer.
Paulovičová E; Paulovičová L; Pilišiová R; Jančinová V; Yashunsky DV; Karelin AA; Tsvetkov YE; Nifantiev NE
Cell Microbiol; 2016 Sep; 18(9):1294-307. PubMed ID: 27310441
[TBL] [Abstract][Full Text] [Related]
26. The Candida albicans phosphomannan complex in Candida-host interactions.
Cutler JE
Res Immunol; 1998; 149(4-5):299-308; discussion 507-9. PubMed ID: 9720948
[No Abstract] [Full Text] [Related]
27. Specificity of the monoclonal antibody 3H8 in the immunohistochemical identification of Candida species.
Järvensivu A; Rautemaa R; Sorsa T; Richardson M
Oral Dis; 2006 Jul; 12(4):428-33. PubMed ID: 16792731
[TBL] [Abstract][Full Text] [Related]
28. Plasma beads loaded with Candida albicans cytosolic proteins impart protection against the fungal infection in BALB/c mice.
Ahmad E; Fatima MT; Saleemuddin M; Owais M
Vaccine; 2012 Nov; 30(48):6851-8. PubMed ID: 23044405
[TBL] [Abstract][Full Text] [Related]
29. Cell wall N-glycan of Candida albicans ameliorates early hyper- and late hypo-immunoreactivity in sepsis.
Kawakita M; Oyama T; Shirai I; Tanaka S; Akaki K; Abe S; Asahi T; Cui G; Itoh F; Sasaki M; Shibata N; Ikuta K; Hatakeyama T; Takahara K
Commun Biol; 2021 Mar; 4(1):342. PubMed ID: 33727664
[TBL] [Abstract][Full Text] [Related]
30. Common and form-specific cell wall antigens of Candida albicans as released by chemical and enzymatic treatments.
López-Ribot JL; Casanova M; Gil ML; Martinez JP
Mycopathologia; 1996; 134(1):13-20. PubMed ID: 8817937
[TBL] [Abstract][Full Text] [Related]
31. Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall.
Faille C; Michalski JC; Strecker G; Mackenzie DW; Camus D; Poulain D
Infect Immun; 1990 Nov; 58(11):3537-44. PubMed ID: 2228224
[TBL] [Abstract][Full Text] [Related]
32. [The significance of Candida serology based on cell wall antigens].
Müller J; Melchinger W
Mycoses; 2004; 47 Suppl 1():2-10. PubMed ID: 15667356
[TBL] [Abstract][Full Text] [Related]
33. [Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease].
Sendid B; Jouault T; Vitse A; Fradin C; Colombel JF; Poulain D
Med Sci (Paris); 2009 May; 25(5):473-81. PubMed ID: 19480828
[TBL] [Abstract][Full Text] [Related]
34. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall.
Vecchiarelli A; Puliti M; Torosantucci A; Cassone A; Bistoni F
Cell Immunol; 1991 Apr; 134(1):65-76. PubMed ID: 1672836
[TBL] [Abstract][Full Text] [Related]
35. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil Attack Triggers Extracellular Trap-Dependent Candida Cell Wall Remodeling and Altered Immune Recognition.
Hopke A; Nicke N; Hidu EE; Degani G; Popolo L; Wheeler RT
PLoS Pathog; 2016 May; 12(5):e1005644. PubMed ID: 27223610
[TBL] [Abstract][Full Text] [Related]
37. Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall.
Hall RA
Mol Microbiol; 2015 Jul; 97(1):7-17. PubMed ID: 25846717
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity of the fungal cell wall.
Pontón J; Omaetxebarría MJ; Elguezabal N; Alvarez M; Moragues MD
Med Mycol; 2001; 39 Suppl 1():101-10. PubMed ID: 11800264
[TBL] [Abstract][Full Text] [Related]
39. Proteomic profiling of serologic response to Candida albicans during host-commensal and host-pathogen interactions.
Pitarch A; Nombela C; Gil C
Methods Mol Biol; 2009; 470():369-411. PubMed ID: 19089396
[TBL] [Abstract][Full Text] [Related]
40. Humoral immune response to Candida albicans.
Jones JM
Immunol Ser; 1989; 47():375-400. PubMed ID: 2490083
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
